Fremont, CA – January 22, 2008 — Optovue, Inc., the first company to introduce a Fourier-domain optical coherence tomography (FD-OCT) system to the US market, today announced that John Hawley has signed on as Vice President of Business Development.

“John has a tremendous amount of experience in a fast growing company environment and an excellent understanding of the eye care market”, stated founder and CEO Jay Wei. “John is well known and respected in this industry, and is a great addition to our management team.”

“The management at Optovue embodies some of the best in this industry on knowledge and experience, and John extends the depth of this asset within Optovue, and what we bring as a company to our customers. We are on course with our infrastructure growth and the steps needed to take Optovue to the next level.”

Mr. Hawley’s previous experience includes Vice President of Heidelberg Engineering where he guided their most successful period of growth in the US over the past 15 years. Previous to Heidelberg, John was the Director of Sales for Octopus in the Western US.

About Optovue

Optovue, Inc., is a privately-held ophthalmic diagnostic company located in Fremont, California. Optovue was founded in 2003 by ophthalmic industry veterans, including developers of the OCT devices sold by Carl Zeiss Meditec (Humphrey), such as StratusTM and VisanteTM. Optovue has assembled a world-class advisory board comprised of thought leaders in ocular disease diagnosis and treatment, including the original inventors of OCT. Optovue is backed by experienced technology and healthcare venture capital firms and private investors.

Optovue launched the RTVue, the first FDA cleared FD-OCT, at the 2006 Annual Meeting of the American Academy of Ophthalmology. Optovue continues to develop innovative products that will expand the clinical utility of OCT and promote ocular health.
www.optovue.com

Back to News